E-ISSN 2231-170X | ISSN 2231-1696
 
2023, Vol: 13, Issue: 1
13 / 1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles

Original Article 


Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria

Paul Columba Inyang-Etoh, Offid Abosede Obi, Mfoniso Iniobong Udonkang.

Abstract
Co-infection of Human Immunodeficiency Virus/Acquired Immune Disease Syndrome (HIV/AIDS) with hepatitis is linked with amplified morbidity and mortality. This study was to investigate the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and hepatitis D virus (HDV) among patients on highly active antiretroviral drug therapy (HAART). A total of 200 subjects currently on HAART and 50 non-HIV positive individuals (control subjects) aged 10-75 years were recruited for the study. Hepatitis B surface antigen and hepatitis C viral antibodies were screened with ACON test strip while HDV was screened with human hepatitis D virus ELISA kit. Demographic data of subjects were obtained with questionnaires. Determination of the CD4 counts was done using the Cytoflow counter. Among the test subjects, prevalence of HBV infection was 16(8%), HCV was 6(3%), mixed infection with HBV and HCV was 2(1%), and HDV was 0(0%). Among the control subjects, infection with HBV was 6(12%), 4(8%) for HCV and none for HDV or mixed infection. There was no statistically significant difference (p=0.491). Males had a higher occurrence of HBV infection 9(11.4%) and HCV infection 4(5.1%) than the females who had 7(5.8%) for HBV and 2(1.6%) for HCV, but this was not statistically significant (p=0.0879). Subjects with CD4 count range of 1401-1600 had the highest occurrence 1(20%) for HBV and 1201-1400 range for HCV 1(8.3%) but the difference was not statistically significant (p=0.504). In conclusion, infection with HBV and HCV is widespread among patients on HAART and routine screening is advocated for efficient management of the disease.

Key words: Calabar, HAART, HBV, HCV, HDV, Prevalence


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Paul Columba Inyang-Etoh
Articles by Offid Abosede Obi
Articles by Mfoniso Iniobong Udonkang
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Paul Columba Inyang-Etoh, Offid Abosede Obi, Mfoniso Iniobong Udonkang. Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria. J Med Allied Sci. 2018; 8(1): 17-21. doi:10.5455/jmas.279731

Web Style

Paul Columba Inyang-Etoh, Offid Abosede Obi, Mfoniso Iniobong Udonkang. Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria. https://jmas.in/?mno=279731 [Access: December 05, 2023]. doi:10.5455/jmas.279731

AMA (American Medical Association) Style

Paul Columba Inyang-Etoh, Offid Abosede Obi, Mfoniso Iniobong Udonkang. Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria. J Med Allied Sci. 2018; 8(1): 17-21. doi:10.5455/jmas.279731


Vancouver/ICMJE Style

Paul Columba Inyang-Etoh, Offid Abosede Obi, Mfoniso Iniobong Udonkang. Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria. J Med Allied Sci. (2018), [cited December 05, 2023]; 8(1): 17-21. doi:10.5455/jmas.279731


Harvard Style

Paul Columba Inyang-Etoh, Offid Abosede Obi, Mfoniso Iniobong Udonkang (2018) Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria. J Med Allied Sci, 8 (1), 17-21. doi:10.5455/jmas.279731


Turabian Style

Paul Columba Inyang-Etoh, Offid Abosede Obi, Mfoniso Iniobong Udonkang. 2018. Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria. Journal of Medical and Allied Sciences, 8 (1), 17-21. doi:10.5455/jmas.279731


Chicago Style

Paul Columba Inyang-Etoh, Offid Abosede Obi, Mfoniso Iniobong Udonkang. "Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria." Journal of Medical and Allied Sciences 8 (2018), 17-21. doi:10.5455/jmas.279731


MLA (The Modern Language Association) Style

Paul Columba Inyang-Etoh, Offid Abosede Obi, Mfoniso Iniobong Udonkang. "Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria." Journal of Medical and Allied Sciences 8.1 (2018), 17-21. Print. doi:10.5455/jmas.279731


APA (American Psychological Association) Style

Paul Columba Inyang-Etoh, Offid Abosede Obi, Mfoniso Iniobong Udonkang (2018) Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria. Journal of Medical and Allied Sciences, 8 (1), 17-21. doi:10.5455/jmas.279731


Author LoginReviewer LoginAbout PublisherEditorial Review PolicyEditorial & Peer Review ProcessConflict of Interest PolicyAdvertising PolicyLicense InformationCopyright Information

About Journal of Medical and Allied Sciences

Welcome to the Journal of Medical and Allied Sciences (JMAS), an official international publication of Deccan College of Medical Sciences, for rapid publi ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


By regular mail/speed post/courier

Dr. Kazi Mudabbir Ahmed
Editor, JMAS,
Deccan College of Medical Sciences,
DMRL ‘X’ Road, Kanchanbagh (PO),
Hyderabad-500 058, Telangana, India.

By email: editorialoffice@jmas.in

By phone: +91 40 24340225, 24340129

By Mobile: +91-8522828349

By fax: +91 40 24340235